Article
Merck's COVID pill does not cut hospitalisation, death rates in many vaccinated adults - study
Rating:
0.0
Views:
84
Likes:
1
Library:
1
Merck & Co Inc's COVID antiviral molnupiravir speeds up recovery but does not reduce the hospitalisation or death rate in higher-risk vaccinated adults, detailed data from a large study showed on Thursday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value